# Post-Market Evaluation of the EVO ICL

> **NCT05538754** · NA · COMPLETED · sponsor: **Staar Surgical Company** · enrollment: 205 (actual)

## Conditions studied

- Myopia
- Myopic Astigmatism

## Interventions

- **DEVICE:** EVO ICL

## Key facts

- **NCT ID:** NCT05538754
- **Lead sponsor:** Staar Surgical Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-23
- **Primary completion:** 2023-09-21
- **Final completion:** 2023-10-04
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05538754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05538754, "Post-Market Evaluation of the EVO ICL". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05538754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*